Results 101 to 110 of about 43,518 (188)

X-ray crystal structure and in silico investigation of Tetrabromo thia-bridged diquinoline including anticancer mechanisms via target prediction and molecular docking. [PDF]

Sci Rep
Alshahateet SF, Al-Mazaideh GM, Al-Trawneh SA, Al-Taweel SA, Jodeh S.   +4 more
europepmc   +1 more source

Genomic Landscape Analysis of Canine Pulmonary Adenocarcinoma Reveals Candidate Targetable Gene Fusions. [PDF]

Vet Comp Oncol
Sakthikumar S, Hendricks WPD, Rainford D, Selleck W, Briones N, Coggins C, Quan N, Zismann V, Lorch G, Sekulic A, Trent JM.   +10 more
europepmc   +1 more source

Protocol for identifying properties of ERBB receptor antagonists using the barcoded ERBBprofiler assay. [PDF]

STAR Protoc
Popović L, Brankatschk B, Rossner MJ, Wehr MC.   +3 more
europepmc   +1 more source

The ErbB-tyrosine kinase inhibitor, neratinib, has anti-inflammatory effects in multimorbidity by increasing macrophage efferocytosis via the upregulation of MerTK. [PDF]

J Inflamm (Lond)
Bowden KA, Wright C, Clark S, Correa TF, Johnston SA, Marriott HM, Francis SE, Prince LR.   +7 more
europepmc   +1 more source

KRAS mutated lung adenocarcinoma responds to pan-ERBB and Aurora kinase inhibitors. [PDF]

NPJ Precis Oncol
Uras IZ, Trkulja MV, Salama AKAA, Horvath J, Asnani K, Trenk C, Kubicek S, Bilban M, Moll HP, Casanova E.   +9 more
europepmc   +1 more source

Expression of p53, c-erbB-2 and Ki67 in intestinal metaplasia and gastric carcinoma. [PDF]

World J Gastroenterol, 2010
Zheng Y, Wang L, Zhang JP, Yang JY, Zhao ZM, Zhang XY.   +5 more
europepmc   +1 more source

Correction to "L-Arginine Activates the Neuregulin-1/ErbB Receptor Signaling Pathway and Increases Utrophin mRNA Levels in C2C12 Cells". [PDF]

Biochem Res Int
europepmc   +1 more source

Recurrent cancer-associated ERBB4 mutations are transforming and confer resistance to targeted therapies. [PDF]

Mol Oncol
Ojala VK, Ahonen S, Peltola S, Tuohisto-Kokko A, Esparta O, Suominen P, Jokilammi A, Farahani I, Chakroborty D, Dibus N, Boettcher S, Airenne TT, Johnson MS, Eli LD, Elenius K, Kurppa KJ.   +15 more
europepmc   +1 more source

ErbB Receptor Feedback Inhibitor 1 Mutation in Biliary Tract Cancers: Turning Resistance Into Response. [PDF]

JCO Precis Oncol
Peshin S, Saj F, Kasi PM, David F, Szklaruk J, Kimana Q, Pant S, Lee SS, Knox JJ, Borad MJ, Javle M.   +10 more
europepmc   +1 more source